CO6950469A2 - Microparticulate pharmaceutical compositions containing antiparasitics for prolonged subcutaneous therapy, use of said pharmaceutical compositions for the production of a medicament and method of treatment of parasitosis - Google Patents

Microparticulate pharmaceutical compositions containing antiparasitics for prolonged subcutaneous therapy, use of said pharmaceutical compositions for the production of a medicament and method of treatment of parasitosis

Info

Publication number
CO6950469A2
CO6950469A2 CO14032937A CO14032937A CO6950469A2 CO 6950469 A2 CO6950469 A2 CO 6950469A2 CO 14032937 A CO14032937 A CO 14032937A CO 14032937 A CO14032937 A CO 14032937A CO 6950469 A2 CO6950469 A2 CO 6950469A2
Authority
CO
Colombia
Prior art keywords
pharmaceutical compositions
parasitosis
antiparasitics
medicament
treatment
Prior art date
Application number
CO14032937A
Other languages
Spanish (es)
Inventor
Bartira Rosse Bergmann
Lima Wallace Pacienza
Bandeira Falcao Camila Alves
Original Assignee
Univ Rio De Janeiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rio De Janeiro filed Critical Univ Rio De Janeiro
Publication of CO6950469A2 publication Critical patent/CO6950469A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CO14032937A 2011-07-18 2014-02-17 Microparticulate pharmaceutical compositions containing antiparasitics for prolonged subcutaneous therapy, use of said pharmaceutical compositions for the production of a medicament and method of treatment of parasitosis CO6950469A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1103229-4A BRPI1103229B1 (en) 2011-07-18 2011-07-18 MICROPARTICULATE PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIPARASITARIES FOR PROLONGED SUBCUTANEOUS THERAPY, USE OF THESE PHARMACEUTICAL COMPOSITIONS FOR THE PRODUCTION OF A MEDICINE AND METHOD OF TREATING PARASITES

Publications (1)

Publication Number Publication Date
CO6950469A2 true CO6950469A2 (en) 2014-05-20

Family

ID=47557597

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14032937A CO6950469A2 (en) 2011-07-18 2014-02-17 Microparticulate pharmaceutical compositions containing antiparasitics for prolonged subcutaneous therapy, use of said pharmaceutical compositions for the production of a medicament and method of treatment of parasitosis

Country Status (3)

Country Link
BR (1) BRPI1103229B1 (en)
CO (1) CO6950469A2 (en)
WO (1) WO2013010238A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105579029B (en) * 2013-09-30 2019-03-05 硕腾服务有限责任公司 Long-acting spiral shell isoxazoline preparation
WO2015177820A1 (en) * 2014-05-19 2015-11-26 Università Degli Studi "Magna Graecia" Di Catanzaro Nanoparticulate systems for vehiculating drugs for the treatment of leishmania infection-related pathologies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492334B2 (en) * 2007-06-21 2013-07-23 Yale University Sustained intraocular delivery of drugs from biodegradable polymeric microparticles

Also Published As

Publication number Publication date
BRPI1103229B1 (en) 2020-10-06
WO2013010238A1 (en) 2013-01-24
BRPI1103229A2 (en) 2013-12-24

Similar Documents

Publication Publication Date Title
HRP20181364T8 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
BR112015003332A2 (en) compound, pharmaceutical composition, use of the compound and method for treating a rorgammat-mediated disease or condition in a patient
BR112015003398A2 (en) compound, pharmaceutical composition, use of the compound and method for treating a rorgammat-mediated disease or condition in a patient
BR112015003397A2 (en) compound, pharmaceutical composition, use of the compound and method for treating a rorgammat-mediated disease or condition in a patient.
BR112015003376A8 (en) pharmaceutically acceptable compound or salt thereof, pharmaceutical composition and uses of efficient amount of pharmaceutically acceptable compound or salt thereof or pharmaceutical composition
BR112014021103A8 (en) antibody, pharmaceutical composition, combination drug, DNA, method of treatment and use of antibody
CL2014002757A1 (en) Compounds derived from benzamide to inhibit the activity of abl1, abl2 and bcr-abl1, pharmaceutical composition; and use in the treatment of cancer.
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
BR112014010177A2 (en) compound, pharmaceutical composition, use of the compound, and method for the prophylaxis or treatment of a disease state or condition
BR112014003802A2 (en) compound, compound pharmaceutical composition, use of a compound, method for making a compound, and preparation of a medicament
BR112014010206A2 (en) compound, pharmaceutical composition, use of compound, and method for the prophylaxis or treatment of a disease state or condition
BR112015002541A2 (en) compound, pharmaceutical composition, use of a compound, and method for treating hcv in a patient.
DK2641614T3 (en) Pharmaceutical preparation integrated with microneedles for skin treatment
BR112014023937A2 (en) pharmaceutical composition, pharmaceutical combination and treatment method
BR112014011671A2 (en) compound, pharmaceutical composition, method for treating a disease or condition, and use of a compound
BR112014010186A2 (en) stable pharmaceutical formulation, kit, pharmaceutical composition, method for preparing a pharmaceutical formulation, and method for treating a human or animal
BR112014032510A2 (en) compound, pharmaceutical composition, method for treating or preventing a disease or disorder, and use of a compound.
BR112014026570A2 (en) microneedle, microneedle arrangement and device, and method for administering a drug
ES2446643R1 (en) Combined pharmaceutical compositions and their use to prepare a drug for the treatment of vertigo, motion sickness and vegetative-vascular dystonia
BR112014025737A2 (en) method for administering a therapeutic agent, method for preventing entry of a therapeutic agent, method for modulating the rate of release of a therapeutic agent, therapeutic agent, dosage forms, method of treating a disease and parts kit
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
BR112014016736A8 (en) compound, pharmaceutical composition, method for treatment, use of a compound and invention
GB201121940D0 (en) Drug treating high blood pressure
BR112015003201A2 (en) compound, pharmaceutical composition, use of a compound and method for treating or ameliorating cancer
BR112013017184A2 (en) compound, pharmaceutical composition, use of a compound, and method for preventing, treating or ameliorating diseases

Legal Events

Date Code Title Description
FC Application refused